Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Stem cells help control the immune response to improve wound healing.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Immune cells called Treg cells are essential for hair growth and regeneration.

Alopecia areata is an autoimmune disease that targets hair follicles.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Hair follicles help skin immune recovery after UVB exposure.

Stat3 affects skin cancer development by altering keratinocyte stem cell behavior.

Neutropenic patients show significant changes in immune cell types and lower neutrophil and natural killer cell percentages.

Moderate immune responses help hair growth, while excessive responses slow it down.

Lower proximal cup cells, not bulge stem cells, regenerate hair follicles after chemotherapy.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Activating TLR3 may help produce retinoic acid, important for tissue regeneration.

Two new mutations in the CDH3 gene cause hair loss and vision problems in a young girl.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

ILC1 cells contribute to hair loss in alopecia areata.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Alopecia areata is linked to reduced T cell function and auto-immunity.